N(G)-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model

Teruo Iwasaki, Masahiko Higashiyama, Keiko Kuriyama, Akira Sasaki, Mutsuko Mukai, Kiyoko Shinkai, Takeshi Horai, Hikaru Matsuda, Hitoshi Akedo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

We investigated the effects of N(G)-nitro-L-arginine-methyl ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, on bone metastasis of human breast cancer, MDA-231 cells. Tumor cells (2 x 10 5 cells in 0.2 ml of phosphate-buffered saline; PBS) were injected through the diaphragm into the left ventricle of the heart of laparotomized nude mice (male 5-week-old ICR-nu/nu). L-NAME (2 mg/mouse/injection in 0.1 ml of PBS) was given intraperitoneally to mice 6 h and 3 h before and immediately, 3 h, 6 h, 18 h and 21 h after the intracardiac injection of tumor cells. As a control, 0.1 ml of PBS was injected instead of L-NAME. The effect of N(G)-nitro-D-arginine methyl ester (D-NAME; 2 mg/mouse/injection), an inactive analogue of L-NAME, was also investigated to evaluate the specificity of L-NAME action. Radiographical examination 31 days after the tumor-cell injection showed that the incidence and number of osteolytic bone metastases and the number of bones with metastasis in L-NAME-treated mice were significantly reduced compared with those in PBS treated mice (P <0.05). The differences between PBS-treated and D-NAME-treated mice were not significant. Our findings suggest that specific and appropriate NOS inhibitors may represent a new pharmacological approach to therapy for cancer patients at risk of developing osteolytic bone metastases.

Original languageEnglish
Pages (from-to)861-866
Number of pages6
JournalJapanese Journal of Cancer Research
Volume88
Issue number9
Publication statusPublished - Sep 1997

Fingerprint

NG-Nitroarginine Methyl Ester
Nude Mice
Breast Neoplasms
Neoplasm Metastasis
Bone and Bones
Injections
Nitric Oxide Synthase
Neoplasms
Diaphragm
Heart Ventricles
Phosphates
Pharmacology
Incidence

Keywords

  • Bone metastasis
  • Human breast cancer
  • N(G)-nitro-L-arginine methyl ester (L-NAME)
  • Nitric oxide (NO)
  • Nude-mouse model

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

N(G)-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model. / Iwasaki, Teruo; Higashiyama, Masahiko; Kuriyama, Keiko; Sasaki, Akira; Mukai, Mutsuko; Shinkai, Kiyoko; Horai, Takeshi; Matsuda, Hikaru; Akedo, Hitoshi.

In: Japanese Journal of Cancer Research, Vol. 88, No. 9, 09.1997, p. 861-866.

Research output: Contribution to journalArticle

Iwasaki, T, Higashiyama, M, Kuriyama, K, Sasaki, A, Mukai, M, Shinkai, K, Horai, T, Matsuda, H & Akedo, H 1997, 'N(G)-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model', Japanese Journal of Cancer Research, vol. 88, no. 9, pp. 861-866.
Iwasaki, Teruo ; Higashiyama, Masahiko ; Kuriyama, Keiko ; Sasaki, Akira ; Mukai, Mutsuko ; Shinkai, Kiyoko ; Horai, Takeshi ; Matsuda, Hikaru ; Akedo, Hitoshi. / N(G)-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model. In: Japanese Journal of Cancer Research. 1997 ; Vol. 88, No. 9. pp. 861-866.
@article{ebc4f6bed7714bc58693e9128f3f387e,
title = "N(G)-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model",
abstract = "We investigated the effects of N(G)-nitro-L-arginine-methyl ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, on bone metastasis of human breast cancer, MDA-231 cells. Tumor cells (2 x 10 5 cells in 0.2 ml of phosphate-buffered saline; PBS) were injected through the diaphragm into the left ventricle of the heart of laparotomized nude mice (male 5-week-old ICR-nu/nu). L-NAME (2 mg/mouse/injection in 0.1 ml of PBS) was given intraperitoneally to mice 6 h and 3 h before and immediately, 3 h, 6 h, 18 h and 21 h after the intracardiac injection of tumor cells. As a control, 0.1 ml of PBS was injected instead of L-NAME. The effect of N(G)-nitro-D-arginine methyl ester (D-NAME; 2 mg/mouse/injection), an inactive analogue of L-NAME, was also investigated to evaluate the specificity of L-NAME action. Radiographical examination 31 days after the tumor-cell injection showed that the incidence and number of osteolytic bone metastases and the number of bones with metastasis in L-NAME-treated mice were significantly reduced compared with those in PBS treated mice (P <0.05). The differences between PBS-treated and D-NAME-treated mice were not significant. Our findings suggest that specific and appropriate NOS inhibitors may represent a new pharmacological approach to therapy for cancer patients at risk of developing osteolytic bone metastases.",
keywords = "Bone metastasis, Human breast cancer, N(G)-nitro-L-arginine methyl ester (L-NAME), Nitric oxide (NO), Nude-mouse model",
author = "Teruo Iwasaki and Masahiko Higashiyama and Keiko Kuriyama and Akira Sasaki and Mutsuko Mukai and Kiyoko Shinkai and Takeshi Horai and Hikaru Matsuda and Hitoshi Akedo",
year = "1997",
month = "9",
language = "English",
volume = "88",
pages = "861--866",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - N(G)-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model

AU - Iwasaki, Teruo

AU - Higashiyama, Masahiko

AU - Kuriyama, Keiko

AU - Sasaki, Akira

AU - Mukai, Mutsuko

AU - Shinkai, Kiyoko

AU - Horai, Takeshi

AU - Matsuda, Hikaru

AU - Akedo, Hitoshi

PY - 1997/9

Y1 - 1997/9

N2 - We investigated the effects of N(G)-nitro-L-arginine-methyl ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, on bone metastasis of human breast cancer, MDA-231 cells. Tumor cells (2 x 10 5 cells in 0.2 ml of phosphate-buffered saline; PBS) were injected through the diaphragm into the left ventricle of the heart of laparotomized nude mice (male 5-week-old ICR-nu/nu). L-NAME (2 mg/mouse/injection in 0.1 ml of PBS) was given intraperitoneally to mice 6 h and 3 h before and immediately, 3 h, 6 h, 18 h and 21 h after the intracardiac injection of tumor cells. As a control, 0.1 ml of PBS was injected instead of L-NAME. The effect of N(G)-nitro-D-arginine methyl ester (D-NAME; 2 mg/mouse/injection), an inactive analogue of L-NAME, was also investigated to evaluate the specificity of L-NAME action. Radiographical examination 31 days after the tumor-cell injection showed that the incidence and number of osteolytic bone metastases and the number of bones with metastasis in L-NAME-treated mice were significantly reduced compared with those in PBS treated mice (P <0.05). The differences between PBS-treated and D-NAME-treated mice were not significant. Our findings suggest that specific and appropriate NOS inhibitors may represent a new pharmacological approach to therapy for cancer patients at risk of developing osteolytic bone metastases.

AB - We investigated the effects of N(G)-nitro-L-arginine-methyl ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, on bone metastasis of human breast cancer, MDA-231 cells. Tumor cells (2 x 10 5 cells in 0.2 ml of phosphate-buffered saline; PBS) were injected through the diaphragm into the left ventricle of the heart of laparotomized nude mice (male 5-week-old ICR-nu/nu). L-NAME (2 mg/mouse/injection in 0.1 ml of PBS) was given intraperitoneally to mice 6 h and 3 h before and immediately, 3 h, 6 h, 18 h and 21 h after the intracardiac injection of tumor cells. As a control, 0.1 ml of PBS was injected instead of L-NAME. The effect of N(G)-nitro-D-arginine methyl ester (D-NAME; 2 mg/mouse/injection), an inactive analogue of L-NAME, was also investigated to evaluate the specificity of L-NAME action. Radiographical examination 31 days after the tumor-cell injection showed that the incidence and number of osteolytic bone metastases and the number of bones with metastasis in L-NAME-treated mice were significantly reduced compared with those in PBS treated mice (P <0.05). The differences between PBS-treated and D-NAME-treated mice were not significant. Our findings suggest that specific and appropriate NOS inhibitors may represent a new pharmacological approach to therapy for cancer patients at risk of developing osteolytic bone metastases.

KW - Bone metastasis

KW - Human breast cancer

KW - N(G)-nitro-L-arginine methyl ester (L-NAME)

KW - Nitric oxide (NO)

KW - Nude-mouse model

UR - http://www.scopus.com/inward/record.url?scp=0030613746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030613746&partnerID=8YFLogxK

M3 - Article

C2 - 9369934

AN - SCOPUS:0030613746

VL - 88

SP - 861

EP - 866

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 9

ER -